Official Answer Key & Detailed Solution
Ready to check the official UPSC Answer Key?
Click any option above to test yourself under exam conditions, or reveal the explanation directly.
Correct Answer: Option (B) — 2 and 3 only
Concept & Option Breakdown
Standard Reference VerifiedStatement 1 is incorrect: Covishield (developed by AstraZeneca/Oxford and produced by SII) is based on a viral vector platform using a modified chimpanzee adenovirus (ChAdOx1), not an mRNA platform. Statement 2 is correct: Sputnik V utilizes a recombinant human adenoviral vector platform (rAd26 for the first dose and rAd5 for the second). Statement 3 is correct: COVAXIN (developed by Bharat Biotech with ICMR-NIV) is an inactivated whole-virion SARS-CoV-2 vaccine.
Practice Full-Length & Sectional Prelims Mocks on this Interface
50 simulated tests in the APT Prelims Test Series (₹1,493) or 1-on-1 Mentorship with Avinash Sir.